Antiviral nanoparticle-formulated mimics of heparan sulfate proteoglycans were developed and shown to permit strong viral association as well as inhibition of a range of viruses on in vitro and in vivo models of infection.
- Valeria Cagno
- Patrizia Andreozzi
- Francesco Stellacci
